Pure Bioscience (OTCMKTS: PURE) and Platform Specialty Products (NYSE:PAH) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and earnings.
This is a breakdown of recent ratings and recommmendations for Pure Bioscience and Platform Specialty Products, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Platform Specialty Products||0||2||4||0||2.67|
Institutional & Insider Ownership
0.2% of Pure Bioscience shares are held by institutional investors. Comparatively, 92.3% of Platform Specialty Products shares are held by institutional investors. 10.6% of Pure Bioscience shares are held by company insiders. Comparatively, 5.2% of Platform Specialty Products shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Risk and Volatility
Pure Bioscience has a beta of -1.35, suggesting that its stock price is 235% less volatile than the S&P 500. Comparatively, Platform Specialty Products has a beta of 3.15, suggesting that its stock price is 215% more volatile than the S&P 500.
Valuation and Earnings
This table compares Pure Bioscience and Platform Specialty Products’ top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Pure Bioscience||$1.83 million||26.03||-$6.26 million||($0.10)||-7.00|
|Platform Specialty Products||$3.78 billion||0.78||-$296.20 million||$0.76||13.53|
Pure Bioscience has higher earnings, but lower revenue than Platform Specialty Products. Pure Bioscience is trading at a lower price-to-earnings ratio than Platform Specialty Products, indicating that it is currently the more affordable of the two stocks.
This table compares Pure Bioscience and Platform Specialty Products’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Platform Specialty Products||-7.84%||7.69%||2.21%|
Platform Specialty Products beats Pure Bioscience on 10 of the 13 factors compared between the two stocks.
Pure Bioscience Company Profile
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. It manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. The company offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a antimicrobial food processing aid for use in poultry processing and produce processing; PURE Multi-Purpose and Floor Cleaner Concentrate used to clean various resilient surfaces, including floors, glass, and food contact surfaces; PURE Multi-Purpose Hi-Foam Cleaner Concentrate used to clean stainless steel equipment, resilient floors, walls, and painted surfaces; and SILVÉRION, an antimicrobial solution used against bacteria, viruses, yeast, and molds. It sells its products to distributors and end users. PURE Bioscience, Inc. was founded in 1992 and is headquartered in El Cajon, California.
Platform Specialty Products Company Profile
Platform Specialty Products Corporation produces and sells specialty chemical products worldwide. It operates through two segments, Performance Solutions and Agricultural Solutions. The Performance Solutions segment offers a range of specialty chemicals, such as surface and coating materials, functional conversion coatings, electronic assembly materials, water-based hydraulic control fluids, and photopolymers. The Agricultural Solutions segment engages in the development, formulation, registration, marketing, and distribution of crop protection solutions, including BioSolutions products and seed treatments for various crops and applications. This segment also offers crop protection chemicals that control biotic stresses, such as fungicides, herbicides, and insecticides. It serves agricultural, animal health, electronics, graphics, plating, offshore oil and gas production, and drilling industries. The company was formerly known as Platform Acquisition Holdings Limited and changed its name to Platform Specialty Products Corporation in October 2013. Platform Specialty Products Corporation was founded in 1922 and is headquartered in West Palm Beach, Florida.
Receive News & Ratings for Pure Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pure Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.